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Oxidative stress participates in the pathophysiology of cystic ﬁbrosis (CF). An underlying disruption in iron homeostasis can frequently be
demonstrated in injuries and diseases associated with an oxidative stress. We tested the hypothesis that iron accumulation and altered expression of
iron-related proteins could be demonstrated in both the bronchoalveolar lavage (BAL) ﬂuid and explanted lungs of patients with cystic ﬁbrosis.
BAL ﬂuid collected from 10 children with CF showed elevated concentrations of protein, iron, ferritin, transferrin, heme, and hemoglobin relative
to that obtained from 20 healthy volunteers. Using Perl's Prussian blue staining, explanted lung from CF patients revealed increased iron in
alveolar and interstitial macrophages. Similarly, there was an increased expression of ferritin, the iron importer DMT1, and the exporter ferroportin
1 in lung tissue from CF patients. We conclude that iron homeostasis is disrupted in CF patients with an accumulation of this metal and altered
expression of iron-related proteins being evident in the lungs.
Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.Keywords: Iron; Ferritin; Cystic ﬁbrosis; Transferrin; Lung diseases1. Introduction
The relationships between the presence of a CFTR mutation,
cell dysfunction, tissue injury, and the variety of clinical
manifestations of cystic fibrosis are not well understood. A
current postulate suggests that abnormal ion transport through
the CFTR protein leads to paradoxical changes in sodium
uptake, dehydrated lining fluid, and a collection of viscous
mucus [1]. This mechanistic theory supports a pathway of injury
in CF which focuses on respiratory and gastrointestinal obstruc-
tion by thickened secretions leading to infection and parenchymal
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http://dx.doi.org/10.1016/j.jcf.2012.10.010Oxidative stress, resulting from both an increased generation
of reactive oxygen species (ROS) by host cells and decreased
anti-oxidant concentrations, is believed to participate in the
pathophysiology of CF [2,3]. Evidence of such oxidative
stress in CF can be observed in elevated measures of plasma
malondialdehyde (MDA) levels [4,5] and 8-isoprostane [4,6] as
well as breath pentane and ethane [7]. Factors which contribute to
an increased production of ROS in CF patients include an airway
inflammation, that can precede the introduction of microbes into
the respiratory tract [8,9], and recurrent infections which are
associated with a further inflammatory influx that produces high
levels of ROS [10]. In addition, individuals with CF can
demonstrate an elevated metabolic rate associated with an
increase of ROS (superoxide and hydrogen peroxide) continu-
ously generated as mitochondrial products of the respiration
process [11]. Regarding anti-oxidants, investigation revealed low
levels of plasma antioxidant vitamins in CF patients with
malabsorption contributing to a decreased uptake of fat solubleystic Fibrosis Society.
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anti-oxidant glutathione have been quantified in the epithelial
lining fluid and serum of CF patients relative to control subjects
[12]. One of the postulated reasons for deficiency of this specific
anti-oxidant is a loss of permeability in the CFTR channel for
glutathione [13,14]. Accordingly, there are several interacting
networks which can produce an increased oxidative stress in CF
patient.
In numerous injuries and diseases associated with an oxidative
stress, an underlying disruption in iron homeostasis can frequently
be demonstrated [15]. There is evidence to support such an
accumulation of iron in the respiratory tract of individuals
diagnosed to have CF [16–18]. We tested the hypothesis that
iron accumulation and altered expression of iron-related proteins
can be demonstrated in the lavage and explanted lungs of CF
patients.
2. Materials and methods
2.1. Bronchoalveolar lavage of patients and healthy volunteers
Bronchoalveolar lavage fluid was obtained from ten children
with CF undergoing clinically indicated bronchoscopy. Details
of bronchoscopy have been previously described [19,20]. Patients
were anesthetized with inhaled sevoflurane and intravenous
propofol. Lidocaine was applied to the vocal cords and carina for
topical anesthesia. Generally, lavage was directed at areas of
either radiographic abnormality or visibly heavy secretion. For
each lavage, 1 mL/kg aliquots (up to a maximum of 20 mL) of
normal saline were instilled and suctioned back through the
bronchoscope. Parents and, as appropriate, patients gave consent
to use of the BAL fluid for research based on an IRB-approved
protocol.
Twenty healthy non-smoking volunteers (18 to 40 years of age)
also underwent fiberoptic bronchoscopy with bronchoalveolar
lavage (BAL). Lidocaine only was employed in anesthesia for
healthy volunteers [21]. The fiberoptic bronchoscope was
wedged into a segmental bronchus of the lingula and then the
right middle lobe. Fifty mL aliquots of sterile saline were
instilled and immediately aspirated (to a total of 250 mL),
centrifuged, and stored at −70 °C. Volunteers consented to the
protocol which had been approved by the University of North
Carolina School of Medicine Committee on the Protection of the
Rights of Human Subjects.
Prior to assays of human lavage samples, comparability was
confirmed by quantifying urea nitrogen concentrations (Thermo
Electron, Louisville, CO).
2.2. Protein, iron, ferritin, and transferrin concentrations in the
BAL fluid
Lavage protein levels were employed as an index of lower
respiratory injury; these were determined using the Pierce
Coomassie Plus Protein Assay Reagent (Pierce, Rockford, IL).
Lavage iron was measured using a colorimetric, enzymatic
method (Sigma Diagnostics, St. Louis, MO). Ferritin concentra-
tions weremeasured using an enzyme immunoassay (MicrogenicsCorporation, Concord, CA). Transferrin concentrations were
analyzed using an immunoprecipitin analysis (INCSTAR Corpo-
ration, Stillwater, MN).2.3. Heme and hemoglobin concentrations in the BAL fluid
Heme and hemoglobin in the lavage were quantified using
colorimetric methodology (QuantiChromHeme and Hemoglobin
Assay Kits; BioAssay Systems, Hayward, CA).2.4. Interleukin (IL)-8 levels in BAL fluid
Lavage fluid was analyzed using ELISA (R&D Systems,
Minneapolis, MN) for interleukin (IL)-8, a pro-inflammatory
mediator whose release strongly correlates with oxidative stress
[22–25].2.5. Histochemistry and immunohistochemisty
Staining was done on six lungs resected from CF patients
receiving transplantation. An equal number of control specimens
were obtained from lung peripheral to neoplasm in patients
having pneumonectomy for resection of lung cancer. All tissues
were freshly obtained. Use of these tissues was deemed exempt
from consent per our institutional IRB.
Tissue sections were cut, floated on a protein-free water
bath, mounted on silane treated slides (Fisher, Raleigh, NC), and
air-dried overnight. Sections were stained for iron using Perl's
Prussian Blue. Immunohistochemistry for ferritin was performed
using a human anti-ferritin antibody (Dako, Carpinteria, CA) at a
dilution of 1:100 [26]. In addition, primary antibodies to divalent
metal transport 1 (DMT1) (generously provided by Dr. Funmei
Yang of the University of Texas, San Antonio, TX) and
ferroportin 1 (FPN1) (generously provided by Dr. David Haile of
the University of Texas, San Antonio, TX) were used at a dilution
of 1:200 [27,28]. Slides were then incubated with biotinylated
linking antibody from Stat-Q Staining System (Innovex Bio-
sciences, Richmond, CA) for 10 min at room temperature, washed
with PBS, and applied peroxidase enzyme label from Stat-Q
Staining System (Innovex Biosciences). After incubation for
10 min at room temperature and washes with PBS, tissue sections
were developed with 3,3′-diaminobenzidine-tetrahydrochloride
for 3 min at room temperature. Sections were counterstained with
hematoxylin, dehydrated through alcohols, cleared in xylene and
coverslipped using a permanent mounting media.2.6. Statistics
Data are expressed as mean value±standard error unless
otherwise specified. T tests of independent means were used to
compare lavage results from the healthy volunteers and patients
with cystic fibrosis. Two-tailed tests of significance were
employed. Significance was assumed at Pb0.05.
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3.1. CF subjects
BAL fluid was obtained from 10 children with CF and a
mean age of 10.8±1.9 years. Four of the CF samples only had
oral flora or no bacterial growth and six showed infection with
typical CF pathogens (Pseudomonas aeruginosa, Burkholderia
multivorans, Staphylococcus aureus andHaemophilus influenzae).
One patient had infection with P. aeruginosa andMycobacterium
massiliense and had the highest heme and hemoglobin measures.
Patients who did not have infection in BAL were younger than
those with infection (5.9±1.4 vs. 14.0±2.3 years). Total cell
counts (305×104 cells/mL) and percent neutrophils (mean 49±
9%) indicated increased inflammation which was higher in those
with current infection (64.8±8.8%) vs. those currently not infected
(25.6±12.9%). Iron indices, iron and iron related proteins did not
differ between the groups nor show a correlation with current
infection in this sub-sample.
3.2. Bronchoalveolar lavage iron and iron-related proteins
Lavage urea nitrogen values from healthy volunteers and CF
patients showed no significant differences (1.3±0.4 and 1.6±
0.5 mg/dL respectively). The lavage protein concentration among
CF patients was significantly increased relative to those fromFig. 1. Measures of protein and iron homeostasis in the lavage from CF patients and h
study cohort (A). Measures of iron, ferritin, transferrin, heme, and hemoglobin were s
relative to healthy subjects.healthy volunteers (Fig. 1A). This difference approximates a
6-fold increase in lavage protein concentration and likely
reflects a tissue injury attributable to inflammation associated
with both CF and complicating infections [16]. Iron levels
were elevated several folds in CF patients (Fig. 1B). Similarly,
lavage concentrations of the metal storage protein ferritin and
the transport protein transferrin were increased among CF
patients (Fig. 1C and D respectively). Finally, both lavage heme
and lavage hemoglobin levels were higher in CF patients which
could suggest micro-bleeds into the lower respiratory tract among
patients with CF (Fig. 1E and F). Changes in iron, ferritin,
transferrin, heme, and hemoglobin concentrations support an
accumulation of iron in the lower respiratory tract among CF
patients. While the lavage heme and hemoglobin concentrations
significantly correlated with each other (with an R greater than
0.95), neither showed significant relationships with lavage iron,
ferritin, and transferrin suggesting that the disruption in metal
homeostasis did not result from hemorrhage alone. Finally,
concentrations of IL-8 in lavage fluid from normal subjects and
patients with cystic fibrosis ranged from 8 to 41 and from 277 to
3130 pg/mL respectively (with means and standard errors of 19±
8 and 453±81 pg/mL). Levels of this pro-inflammatory mediator
supported increased oxidative stress in the lower respiratory
tract among patients with CF. IL-8 concentrations significantly
correlated with lavage protein, ferritin, and iron (R=0.65,
0.81, and 0.67 respectively).ealthy volunteers. Protein was elevated in CF patients reflecting an injury in this
imilarly significantly elevated among CF patients (B–F). *Significantly elevated
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Lung tissue from controls (those patients treated for lung
cancer with pneumonectomy) showed neither retained particle
nor metal on Perl's Prussian blue stain for iron (Fig. 2A). Airway
epithelium did not stain positively for iron in CF patients.
However, the most distal respiratory tract of the explanted lungs
showed positive Perl's stain by macrophages either in the
alveolar lumen (Fig. 2B) or in the interstitium (Fig. 2C and D).
Ferritin is the intracellular site for iron storage and a major
iron-related protein whose expression increases with metal
accumulation. Airway epithelial cells demonstrated positive
staining for ferritin in control lungs. Uptake for the ferritin
antibody by epithelium in the control lungs was less likely in
the more distal airways. Macrophages within the airways from
controls were found to stain positively for ferritin regardless of
whether it was a cartilaginous bronchus, membranous bronchus,
terminal bronchiole, or respiratory bronchiole. There was minimal
uptake for the ferritin antibody in the small airways of the distal
respiratory tract in control subjects (Fig. 3A). In the airways of
explanted lung from patients with cystic fibrosis, there was an
increased ferritin expression compared to control and this staining
pattern showed regional heterogeneity. Several different patterns
of uptake for the ferritin antibody were evident. In the first,
staining for this storage protein was observed at the base of
columnar epithelium of the large airways in cystic fibrosis patients
(Fig. 3B) and in inflammatory cells in the submucosal region of
the airway showed uptake of the ferritin antibody (Fig. 3B). In theFig. 2. Perl's Prussian blue stain for iron. Lung tissue collected by pneumonectomy
was a significant increase in iron stain (blue color) in explanted lung from CF pati
Magnification approximates 100×.second pattern of uptake for ferritin, epithelial cells immediately
adjacent to significant inflammation frequently demonstrated a
total lack of ferritin staining while the inflammatory cells, both in
the airway and in the submucosa showed high levels of expression
(Fig. 3C). In a third pattern of uptake for this antibody, other
regions of the CF tissue could display high expression of ferritin
both in the epithelial cells and in the influxed inflammatory cells
within the submucosa (Fig. 3D). In the more distal units of the
lung, ferritin expression was increased among samples from CF
patients. The control lungs demonstrated occasional staining for
ferritin but this was almost exclusively restricted to intra-alveolar
macrophages (Fig. 4A). In explanted CF lung, ferritin stain of the
most distal portion of the respiratory tract showed positive uptake
bymacrophages and inflammatory cells within the alveoli (Fig. 4B
and C). In addition, there could be uptake of the ferritin antibody
by macrophages in the interstitium of the distal respiratory tract
(Fig. 4D).While not uniform, there was an increased expression of
ferritin in both the airways and the periphery of all lung samples
from CF patients.
3.4. Divalent metal transporter 1 and ferroportin 1 in lung
tissue
Divalent metal cations must be transported across cell
membranes by metal carrier proteins. DMT1 is a major iron
importer and subsequently its expression was evaluated. In the
control lungs, there was uptake for the DMT1 antibody at both
the apical surface of the epithelial cells and at the basementfor lung cancer showed no evidence of iron accumulation (A). In contrast, there
ents (B–D). Iron appeared to localize to alveolar and interstitial macrophages.
Fig. 3. Immunohistochemistry for ferritin in the airways. Airways from non-CF lungs showed little to no staining for ferritin (A). Bronchi and bronchioles from CF
patients demonstrated some uptake of the antibody (B–D; orange to brown color). The pattern of staining could reveal variability with those airways involved in
inflammation showing little staining by epithelial cells but elevated expression of the storage protein in the inflammatory cells themselves (B). Airway epithelium
could also exhibit increased staining for ferritin immediately adjacent to the basement membrane (C) and throughout the mucosa and submucosa (D). Magnification
approximates 100×.
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epithelium continued to stain positively for this importer (Fig. 5B).
In addition, alveolar macrophages were observed to show
significant uptake of the DMT1 antibody (Fig. 5B). In the large
airways of CF explanted lung, DMT1 expression was signifi-
cantly increased in the epithelial layer and in inflammatory cells
of the lamina propria and the submucosa (Fig. 5C). In the alveolar
region of the explants, DMT1 expression was increased and
localized to intra-alveolar and interstitial macrophages (Fig. 5D).
The expression of the iron exporter FPN1 was the final protein
examined. There was little expression of FPN1 in the control lungs
in the airways (Fig. 6A) and distal respiratory tract (Fig. 6B).
Explanted lung from CF patients showed elevated levels of
staining for FPN1, specifically in epithelial cells in distal airways
(Fig. 6C). Additionally, inflammatory cells in the lamina propria
and the submucosa of the airways in explanted tissue stained
positive for FPN1 (Fig. 6C). In the alveolar region, there was a
positive FPN1 staining in alveolar and interstitial macrophages
(Fig. 6D).
4. Discussion
Measurement of iron and ferritin in BAL fluid revealed elevated
levels of both in patients with CF relative to healthy volunteers.
These results confirm prior investigation which similarly showed
elevations in iron and ferritin in respiratory samples. Comparedwith control subjects, concentrations of iron and ferritin in sputum
were observed to be increased in patients with CF [18]. In a second
study utilizing sputum samples collected from CF patients, iron
and ferritin (as well as microalbumin) were significantly elevated
relative to normal controls and patients with COPD [16]. Further,
sputum iron and ferritin concentrations correlated with each other
(as well as with sputum cytokines) and ferritin levels were further
elevated in CF patients during disease exacerbation. In addition to
sputum, BAL fluid from patients with CF was previously
demonstrated to have elevated concentrations of iron and
iron-related proteins [17]. Iron was detected in BAL fluid from
patients with CF but not healthy non-smokers. Ferritin was present
in all BAL fluid with higher total ferritin in patients with CF
relative to healthy non-smokers. While iron and ferritin levels
have been repeatedly observed to be elevated in CF patients, the
concentration of transferrin in respiratory samples from this group
has varied. Relative to healthy volunteers, we observed an
elevated transferrin level in the lavage fluid collected from our
CF cohort while other studies have shown reduced sputum
and equivalent lavage transferrin concentrations [17,18].
While changes in transferrin can reflect a disruption in the
iron homeostasis of the respiratory tract, a major source of this
glycoprotein is its translocation from the blood to the lower
respiratory tract [29]. Increases in lavage transferrin observed
in our study may reflect an injury to the alveolar-capillary
membrane and elevated vascular permeability among CF
Fig. 4. Immunohistochemistry for ferritin in the alveolar region. The control (non-CF) lungs could show positive staining for ferritin in alveolar macrophages
(A; orange to brown color). Explanted lung from CF patients demonstrated increased uptake of ferritin antibody in both alveolar and interstitial macrophages (B–D). In
at least one CF patient, ferritin staining showed numerous intra-alveolar macrophages in a pattern resembling desquamative interstitial pneumonitis (C). Magnification
approximates 100×.
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were elevated concentrations of both heme and hemoglobin in
the lavage fluid from CF patients. This may reflect bleeding in
the lower respiratory tract of these individuals which will
further affect an accumulation of iron following the action of
heme oxygenase in resident cells. Additionally, the presence
of heme, an essential nutrient for many bacteria, can enhance
bacterial growth.
Explanted lung has not previously been examined for
evidence of a disruption in iron homeostasis. Histologic and
immunohistologic assessment of the explanted lung supported an
accumulation of iron in the CF lung. Iron was stainable in the
macrophages of the distal respiratory tract (both alveolar and
interstitial). This specific metal can catalyze electron exchange
with the subsequent oxidant generation which damages host
tissues. The sequestration of iron with control of its capacity to
support oxidant generation requires storage within ferritin [31,32].
The increased expression of ferritin observed in the explanted
lungs from CF patients can reflect increased concentrations of
biologically available iron. In the staining for ferritin, elevations in
the expression of this protein were observed in the airways and the
alveolar region in the explanted lungs of CF patients. Airway
epithelial cells, inflammatory cells in the lamina propria,
submucosa, and bronchus lumen itself, and alveolar and interstitial
macrophages in the distal lung units all demonstrated significant
uptake of the ferritin antibody. The heterogeneity of ferritinlocalization in explanted CF lungs cannot be explained with
certainty; it may reflect the heterogeneity of the lung injury in
cystic fibrosis or other factors such as exposure to microbes and
particles [33,34].
Staining for the iron importer DMT1 and exporter FPN1
demonstrated comparable elevations in expression in explanted
CF lung tissue. DMT1 is a member of the natural resistance-
associated macrophage proteins (Nramp) present in most tissues
and cell types as an integral membrane protein (with a molecular
weight of 90 to 100 kD) modified by glycosylation [35]. Its
ubiquitous expression suggests that it might be involved in
transferrin-independent iron uptake [36]. In tissues which do not
function to meet the nutritional requirements of the living system
such as the lung, DMT1 may serve to diminish the oxidative
stress and injury which iron presents. Accordingly, expression
would be expected to be increased. With intracellular transport,
iron could then be stored in ferritin and free radical generation
would diminish. While cellular uptake of excess iron can limit the
degree of toxicity in the lung, storage in this intracellular site is
vulnerable to mobilization. FPN1 functions as such an exporter in
lung cells and iron can augment its expression [37]. Both DMT1
and FPN1 participate in iron recycling and detoxification [38]
and, comparable to ferritin, changes in the expression of these
proteins support a disruption in iron homeostasis in CF.
In this study, concentrations of iron and iron-related proteins
were observed to be altered in CF patients. The issue of whether
Fig. 5. Immunohistochemistry for DMT1. Tissue from non-CF patients revealed staining for the iron importer at the most apical portions of airway epithelial cells and
at the basement membrane (A; orange to brown color). These control lungs also showed uptake for DMT1 in the smaller airways and alveolar macrophages (B). CF
explanted lung demonstrated greatly elevated expression in both the respiratory epithelium (including the epithelial and inflammatory cells) and inflammatory cells in
the alveolar region (C and D). Magnification approximates 100×.
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pathogenesis of this disease is not addressed by this investigation.
Iron accumulation could be a process directly associated with the
pathophysiology of cystic fibrosis; the disruption of its homeo-
stasis could participate in initiating inflammation and infection
[39]. Alternatively, the accumulation of the metal could be the
result of the infection. Regardless, elevated concentrations of iron
in the lower respiratory tract of patients with cystic fibrosis
correlate with the risk for infection [16,40]. However, it has been
previously described that children dying with CF as early as
3 months of age can show an abnormal accumulation of the metal
[41]. This observation would suggest that the disruption in iron
homeostasis observed in this and other studies is not the result of
chronic inflammation and infection. It is possible that iron
concentrations are increased in the respiratory tract of CF patients
through an abnormality of metal transport inherent to this disease.
Possible mechanisms through which iron transport might be
altered in CF include a disruption of chloride and sodium import
pathways. Interactions between chloride, sodium and iron transport
have been suggested by prior investigations [42,43]. If the basic
abnormal chemistry of the defect in CF were to include an
abnormal transport of iron, the relationship between an increased
incidence of infection (e.g. P. aeruginosa) and its dependence on
available metal could be better appreciated [44]. Furthermore,
descriptions of anemia in CF could subsequently be appreciated asa possible secondary manifestation of the disruption in iron
homeostasis comparable to an anemia of chronic disease [45,46].
Treatment with iron would be avoided until absolutely required
possibly decreasing both worsening of CF and risk for infection.
We conclude that iron homeostasis is disrupted in the lungs
of patients with cystic fibrosis both in early and end-stage lung
diseases. There is an accumulation of iron in the respiratory
tract in CF associated with altered expression of several iron-
related proteins including ferritin, DMT1, and FPN1. Future
studies, likely utilizing animal models, are required to examine
whether these changes are secondary to inflammation and
infection or centrally involved in the pathogenesis of this
disease. In addition, further human investigation into systemic
and lung iron homeostasis may be possible utilizing non-
invasive measures such as magnetic resonance imaging.
Disclaimer
This report has been reviewed by the National Health and
Environmental Effects Research Laboratory, United States
Environmental Protection Agency and approved for publica-
tion. Approval does not signify that the contents necessarily
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Fig. 6. Immunohistochemistry for FPN1. Tissue collected from controls revealed little to no staining for the iron exporter FPN1 in either the airways (A) or the distal
respiratory tract (B). FPN1 staining was augmented in explanted lung from CF patients. Staining was elevated in airway epithelial cells, inflammatory cells, and
alveolar macrophages of the alveolar region (C–D; orange to brown color). Magnification approximates 100×.
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